Dr. Gjumrakch Aliev, MD, PhD, President “GALLY” International Biomedical Research Institute Inc., San Antonio, Texas, USA. He also hold appointment with the University of Atlanta, Atlanta, Georgia, USA as a Professor of Cardiovascular, Neuropathology, Gerontology, Health Science and Healthcare Administration. He received his MD in 1982, from the Baku Medical University (former USSR) with cum laude. Then he accomplished his PhD in Cardiovascular Diseases from the prestigious Russian Academy of the Medical Sciences, Moscow, Russia in 1988 with cum laude. He received postdoctoral training with Professor G. Burnstock in the University College of the London. He authored and coauthored more than 500 publications in the fields of neurodegenerative diseases research (Alzheimer disease), as well as cardio- and cerebrovascular disease, cancer, and electron microscopy. He is an outstanding teacher, scholar, and a renowned scientist in the area of cellular molecular physiology, and cardiovascular, and neurodegeneration-mediated pathologies and drug development including Alzheimer disease (AD). He is nationally and internationally reputed in his area.

Dr. Aliev’s accomplishments in the area of biochemistry and cellular biology have tremendous implications for drug design towards CNS Neurological Disorders, AD, cancer, and cerebrovascular and neurodegeneration related pathologies. He is world-renowned expert in electron microscopy. His work has been published in numerous prestigious journals such as Nature Clinical Cardiology, J. Neuroscience, Circulation Research, New England journal of Medicine, Blood, J. Cellular and Molecular Medicine, Atherosclerosis, CNS Neurological Disorders & Drug Targets, International J. Biochemistry and Cell Biology, Scientific Reports, and many others which reflect his leading role in his research areas. He is currently the Editor in Chiefs for “Central Nervous System Agents in Medicinal Chemistry”, “Applied Cell Biology”, “World Journal of Neuroscience”, “Open Journal of Psychiatry” and “Journal of Aging Science”, Cardiovascular & Hematological Agents in Medicinal Chemistry as well as which by itself shows the voluminous and outstanding work he has accomplished in the area of cellular and molecular biology as well as aged associated clinical sciences. He is one of most cited authors in his fields with high impact factors.

Kedar N. Prasad obtained a Master’s degree in Zoology from the University of Bihar in India, and a Ph.D. degree in Radiation Biology from the University of Iowa, Iowa City. He went to Brookhaven National Laboratory for Post-doctoral training in Parkinson disease. Dr. Prasad Joined the Department of Radiology at the University of Colorado School of Medicine where he became Professor and Director for the Center for Vitamins and Cancer Research. During his distinguish career, he has published over 250 papers in peer-reviewed journals including Nature, Science, and Proceedings of the National Academy of Sciences (PNAS) supported by the National Institutes of Health (NIH). He also contributed several book chapters and abstracts as well as authored or edited 25 books on radiobiology, neurodegenerative disease, and nutrition and cancer. He has written books on Alzheimer’s disease, Parkinson disease, and PTSD for the consumers. He has been a member of numerous professional organizations, and served as an ad-hoc member of various Study Sections of the NIH. He was frequently invited to speak at the several National and International meetings including very prestigious conferences, such as Princess Takamatsu Cancer Conference in Tokyo, Cold Spring Harbor meeting on Differentiation of Cancer Cells in Long Island, New York; and NATO Conference on Radiation Protection in Kiev, Ukraine. Best Review paper of 1998-1999 on Antioxidant and Cancer; Best Review paper of 1999-2000 0n Antioxidant and Parkinson disease; and Beast Research paper of 2001-2002 on Antioxidant and Statin Drugs. He delivered the 1999 Harold Harper Lecture at the meeting of the American College of Advancement of Medicine. In 1982, he was invited by the Nobel Prize Committee to nominate a candidate for the Nobel Prize in Medicine. He is a former President of the International Society for Nutrition and Cancer. He is a former Chief Scientific Officer of the Premier Micronutrient Corporation. Currently, he is an independent consultant for nutritional industries, and serves as a Chief Scientific Advisor to Engage Global

Radiation Biology, Nutrition and Pharmacology

Phila Raharivelomanana obtained her PhD diploma in Molecular Chemistry at the University of Nice Sophia-Antipolis (France) on 1992 and her Habilitation diploma on 1997 at the same university. She have more than 20 years of experience in phytochemical sciences research in academic aspect. Since 1993, she was faculty position at the University of French Polynesia (respectively Assistant professor on 1992, Associate professor on 1993 and Full professor on 2004) as a chemist teacher and phytochemist researcher working on tropical plants studies and especially Pacific and Polynesian plants. When she joined the UPF in 1990’s, she was one of the pioneer researchers working in phytochemistry of Polynesian plants and she focussed her interests on aromatic plants mostly on sesquiterpene containing plants. Then, she moved to plant uses investigation aiming a better understanding of ethnopharmacological regards (Pharmacopoeia and Cosmetopoeia) and an evaluation of their biological activities beyond their chemical composition assessment including studies of a wide variety of bioactive secondary metabolites (terpenes, alkaloids, polyphenols...) contents. Since 2011, she is a scientific member of national committee of French universities (CNU) in organic and inorganic chemistry in France. She is member of the Editorial advisory board of Natural Product Communications journal

Her research interests concern the following topics: Pacfic and Polynesian plants and their uses (Pharmacopoeia and Cosmetopoeia), Aromatic and medicinal plants, Natural product chemistry, Secondary metabolites (Terpenoids, Alkaloids, Polyphenolic compounds), Structural elucidation, Biological activity assessment (antioxidant, antimicrobial, anti-ageing, odor active compounds….), Plant and Biodiversity conservation.

Dr. Christophe Wiart is the general secretary of the Asian Society of Pharmacognosy. Dr. Christophe Wiart appeared on HBO's Vice (TV Series) in season 3, episode 6 (episode 28 of the series), titled "The Post-Antibiotic World & Indonesia's Palm Bomb." This episode aired on April 17, 2015. This episode highlighted the need to find new treatments for infections that were previously treatable with antibiotics, but are now resistant to multiple drugs. “The last hope for the human race’s survival, I believe, is in the rainforests of tropical Asia,” said ethnopharmacologist Dr. Christophe Wiart. “The pharmaceutical wealth of this land is immense.”

Christophe Wiart PharmD, PhD, ASP (born August 12, 1967) is a French Pharmacognosist. His fields of expertise are Asian ethnopharmacology, chemotaxonomy and ethnobotany. He has collected and studied several hundred species of medicinal plants of Southeast Asia. Ethnopharmacology of medicinal plants in Asia Pacific; bioprospection, collection and identification of medicinal botanical samples and phytochemical and pharmacological study for the identification of lead compounds as novel antibacterial, antiviral, anticancer, and anti-diabetic principles from rare plants from the rainforest of Southeast Asia and from medicinal plants used by locals

Over the past 20 years Dr Ian Martins has been a reviewer for various international journals and research grant agencies and is the Chief Editor for Scientific and Academic Publishing. ResearchGate’s analysis of Dr Martins’ publication stats place the RG score higher than 93% of the international researchers. Dr. Ian Martins received the Richard Kuhn Research Award-2015 in Endocrinology and Metabolism. Contribution to biology is the peripheral sink abeta hypothesis with relevance to obesity and Alzheimer’s disease. Dietary Interventions early in life activate the hepatic calorie sensitive gene Sirtuin 1 with relevance to alpha synuclein and peripheral amyloid beta clearance.

Ethnopharmacology, Pharmacology

Mohammed Hmamouchi has obtained PhD in Phytochemistry (1986, Laval University in Canada). After his graduation, he gets research and teaching positions in the faculty of medicine and pharmacy in Rabat. In 1999, he has published his first main book; it is the fruit of several years of research and reflection, on Medicinal and Aromatic Plants in Morocco. In 2004 he was appointed by Moroccan government to develop and implement national policies on Medicinal and Aromatic Plants. He oversaw build and equipment. He leads, as a Director, of a First National Institute on Medicinal and Aromatic Plants (African and Arab). In 2011 he became President of the Arab Federation of Medicinal and Aromatic Plants. He was also the focal point of different international conventions and agreements, and coordinator of national and international MAP networks (Tempus: European Union Projects). He managed several research projects, contracts and cooperation agreement. He assisted business creation, cooperatives for the production of MAP and product development opportunities. He has worked with many international institutions and companies in over 30 countries. He is a member of several professional bodies and has received many grants and awards. In 2013 he became Advisor to the Minister of Higher Teacher Education, Scientific Research. Dr. Hmamouchi continuing to do research, to be invited to give plenary lectures at the Congress (Guest Speakers) and also to make expertise.

Dr. Hmamouchi has researched in the following areas: Ethnomedicine, Ethnopharmocology, Agronomy, Phytochemistry, Biological Activity, Pharmacognosy, Pharmacology & Toxicology, Conservation of Medicinal, Phytomedicines, perfumery, culinary herbs, Aromatic plants and Herbal Plants, Crops Marketing & Trade. He headed several departments and agencies for training, research, innovation. He has published more than 100 papers in reputed journals, 4 books and has been serving as an editorial board member and Chief Editor of International Journal (www. AJMAP.org). He received many grants and awards such as the ISESCO, President of the Republic of Tunisia and European Business Innovation (Clusters).

Dr Yibin Feng is currently an Associate Professor cum Associate Director (Education) in School of Chinese Medicine, the University of Hong Kong. Dr. Feng awarded Bachelor degree in Chinese Medicine from Mainland China. He awarded his PhD degree in molecular medicine from Hokkaido University School of Medicine and finished postdoctoral research in the same University in Japan. Dr. Feng’s research interest focuses on clinical trial and experimental study for cancer, diabetes, hepatic and renal diseases by using recently developed techniques. He has published over 200 publications in these areas and serve as editor and reviewer for over 50 international journals

Pharmacology and ethnopharmacology